## **Core Concept**
Efavirenz is an antiretroviral medication used to treat HIV infection. It belongs to the class of non-nucleoside reverse transcriptase inhibitors (NNRTIs). The core concept here involves understanding the mechanism of action of efavirenz in limiting HIV infection.

## **Why the Correct Answer is Right**
Efavirenz works by selectively inhibiting the reverse transcriptase enzyme of HIV, which is essential for the replication of the virus. By binding to the reverse transcriptase enzyme, efavirenz induces a conformational change that prevents the enzyme from performing its role in viral DNA synthesis. This action is specific to the HIV reverse transcriptase and does not significantly affect human DNA polymerases.

## **Why Each Wrong Option is Incorrect**
- **Option A:** This option is incorrect because efavirenz does not act by inhibiting viral entry into the host cell. HIV entry inhibitors are a different class of antiretroviral drugs.
- **Option B:** This option is incorrect because efavirenz does not work by inhibiting viral protease. Protease inhibitors are another class of antiretroviral drugs that work at a different step in the HIV replication cycle.
- **Option D:** This option is incorrect because efavirenz does not act by stimulating the host immune response. Immunomodulators or vaccines might work through such mechanisms, but efavirenz directly targets viral replication.

## **Clinical Pearl / High-Yield Fact**
A key point to remember is that efavirenz can cause central nervous system (CNS) side effects, such as vivid dreams, dizziness, and depression, which can limit its tolerability in some patients. This is a high-yield fact for exams because it helps in distinguishing efavirenz from other antiretroviral drugs based on side effect profiles.

## **Correct Answer:** C. Inhibiting reverse transcriptase.